report cover

Global and United States Ketorolac Tromethamine Market Report & Forecast 2022-2028

  • 06 October 2022
  • Life Sciences
  • 119 Pages
  • Report code : 24WT-7413564

Ketorolac Tromethamine Market

1 Study Coverage
1.1 Ketorolac Tromethamine Product Introduction
1.2 Global Ketorolac Tromethamine Outlook 2017 VS 2022 VS 2028
1.2.1 Global Ketorolac Tromethamine Sales in US$ Million for the Year 2017-2028
1.2.2 Global Ketorolac Tromethamine Sales in Volume for the Year 2017-2028
1.3 United States Ketorolac Tromethamine Outlook 2017 VS 2022 VS 2028
1.3.1 United States Ketorolac Tromethamine Sales in US$ Million for the Year 2017-2028
1.3.2 United States Ketorolac Tromethamine Sales in Volume for the Year 2017-2028
1.4 Ketorolac Tromethamine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Ketorolac Tromethamine in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Ketorolac Tromethamine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Ketorolac Tromethamine Market Dynamics
1.5.1 Ketorolac Tromethamine Industry Trends
1.5.2 Ketorolac Tromethamine Market Drivers
1.5.3 Ketorolac Tromethamine Market Challenges
1.5.4 Ketorolac Tromethamine Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Ketorolac Tromethamine Market Segment by Type
2.1.1 Injection
2.1.2 Ophthalmic
2.1.3 Nasal
2.1.4 Oral tablet
2.2 Global Ketorolac Tromethamine Market Size by Type
2.2.1 Global Ketorolac Tromethamine Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Ketorolac Tromethamine Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Ketorolac Tromethamine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Ketorolac Tromethamine Market Size by Type
2.3.1 United States Ketorolac Tromethamine Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Ketorolac Tromethamine Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Ketorolac Tromethamine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Ketorolac Tromethamine Market Segment by Application
3.1.1 Short-term treatment of pain
3.1.2 Ophthalmic Surgery
3.2 Global Ketorolac Tromethamine Market Size by Application
3.2.1 Global Ketorolac Tromethamine Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Ketorolac Tromethamine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Ketorolac Tromethamine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Ketorolac Tromethamine Market Size by Application
3.3.1 United States Ketorolac Tromethamine Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Ketorolac Tromethamine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Ketorolac Tromethamine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Ketorolac Tromethamine Competitor Landscape by Company
4.1 Global Ketorolac Tromethamine Market Size by Company
4.1.1 Top Global Ketorolac Tromethamine Manufacturers Ranked by Revenue (2021)
4.1.2 Global Ketorolac Tromethamine Revenue by Manufacturer (2017-2022)
4.1.3 Global Ketorolac Tromethamine Sales by Manufacturer (2017-2022)
4.1.4 Global Ketorolac Tromethamine Price by Manufacturer (2017-2022)
4.2 Global Ketorolac Tromethamine Concentration Ratio (CR)
4.2.1 Ketorolac Tromethamine Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Ketorolac Tromethamine in 2021
4.2.3 Global Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Ketorolac Tromethamine Manufacturing Base Distribution, Product Type
4.3.1 Global Ketorolac Tromethamine Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Ketorolac Tromethamine Product Type
4.3.3 Date of International Manufacturers Enter into Ketorolac Tromethamine Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Ketorolac Tromethamine Market Size by Company
4.5.1 Top Ketorolac Tromethamine Players in United States, Ranked by Revenue (2021)
4.5.2 United States Ketorolac Tromethamine Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Ketorolac Tromethamine Sales by Players (2020, 2021 & 2022)
5 Global Ketorolac Tromethamine Market Size by Region
5.1 Global Ketorolac Tromethamine Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Ketorolac Tromethamine Market Size in Volume by Region (2017-2028)
5.2.1 Global Ketorolac Tromethamine Sales in Volume by Region: 2017-2022
5.2.2 Global Ketorolac Tromethamine Sales in Volume Forecast by Region (2023-2028)
5.3 Global Ketorolac Tromethamine Market Size in Value by Region (2017-2028)
5.3.1 Global Ketorolac Tromethamine Sales in Value by Region: 2017-2022
5.3.2 Global Ketorolac Tromethamine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Ketorolac Tromethamine Market Size YoY Growth 2017-2028
6.1.2 North America Ketorolac Tromethamine Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Ketorolac Tromethamine Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Ketorolac Tromethamine Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Ketorolac Tromethamine Market Size YoY Growth 2017-2028
6.3.2 Europe Ketorolac Tromethamine Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Ketorolac Tromethamine Market Size YoY Growth 2017-2028
6.4.2 Latin America Ketorolac Tromethamine Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Ketorolac Tromethamine Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Ketorolac Tromethamine Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Corporation Information
7.1.2 Pfizer Description and Business Overview
7.1.3 Pfizer Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Pfizer Ketorolac Tromethamine Products Offered
7.1.5 Pfizer Recent Development
7.2 Omeros Corporation
7.2.1 Omeros Corporation Corporation Information
7.2.2 Omeros Corporation Description and Business Overview
7.2.3 Omeros Corporation Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Omeros Corporation Ketorolac Tromethamine Products Offered
7.2.5 Omeros Corporation Recent Development
7.3 Egalet US Inc.
7.3.1 Egalet US Inc. Corporation Information
7.3.2 Egalet US Inc. Description and Business Overview
7.3.3 Egalet US Inc. Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Egalet US Inc. Ketorolac Tromethamine Products Offered
7.3.5 Egalet US Inc. Recent Development
7.4 Allergan
7.4.1 Allergan Corporation Information
7.4.2 Allergan Description and Business Overview
7.4.3 Allergan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Allergan Ketorolac Tromethamine Products Offered
7.4.5 Allergan Recent Development
7.5 Dr. Reddy?s Laboratories
7.5.1 Dr. Reddy?s Laboratories Corporation Information
7.5.2 Dr. Reddy?s Laboratories Description and Business Overview
7.5.3 Dr. Reddy?s Laboratories Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Dr. Reddy?s Laboratories Ketorolac Tromethamine Products Offered
7.5.5 Dr. Reddy?s Laboratories Recent Development
7.6 Teva
7.6.1 Teva Corporation Information
7.6.2 Teva Description and Business Overview
7.6.3 Teva Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Teva Ketorolac Tromethamine Products Offered
7.6.5 Teva Recent Development
7.7 Mylan
7.7.1 Mylan Corporation Information
7.7.2 Mylan Description and Business Overview
7.7.3 Mylan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Mylan Ketorolac Tromethamine Products Offered
7.7.5 Mylan Recent Development
7.8 West Ward Pharmaceuticals
7.8.1 West Ward Pharmaceuticals Corporation Information
7.8.2 West Ward Pharmaceuticals Description and Business Overview
7.8.3 West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.8.4 West Ward Pharmaceuticals Ketorolac Tromethamine Products Offered
7.8.5 West Ward Pharmaceuticals Recent Development
7.9 Fresenius Kabi
7.9.1 Fresenius Kabi Corporation Information
7.9.2 Fresenius Kabi Description and Business Overview
7.9.3 Fresenius Kabi Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Fresenius Kabi Ketorolac Tromethamine Products Offered
7.9.5 Fresenius Kabi Recent Development
7.10 Apotex
7.10.1 Apotex Corporation Information
7.10.2 Apotex Description and Business Overview
7.10.3 Apotex Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Apotex Ketorolac Tromethamine Products Offered
7.10.5 Apotex Recent Development
7.11 Sandoz
7.11.1 Sandoz Corporation Information
7.11.2 Sandoz Description and Business Overview
7.11.3 Sandoz Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Sandoz Ketorolac Tromethamine Products Offered
7.11.5 Sandoz Recent Development
7.12 Amphastar Pharmaceuticals
7.12.1 Amphastar Pharmaceuticals Corporation Information
7.12.2 Amphastar Pharmaceuticals Description and Business Overview
7.12.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Amphastar Pharmaceuticals Products Offered
7.12.5 Amphastar Pharmaceuticals Recent Development
7.13 Gland Pharma Limited
7.13.1 Gland Pharma Limited Corporation Information
7.13.2 Gland Pharma Limited Description and Business Overview
7.13.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Gland Pharma Limited Products Offered
7.13.5 Gland Pharma Limited Recent Development
7.14 Akorn
7.14.1 Akorn Corporation Information
7.14.2 Akorn Description and Business Overview
7.14.3 Akorn Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Akorn Products Offered
7.14.5 Akorn Recent Development
7.15 Sun Pharmaceutical
7.15.1 Sun Pharmaceutical Corporation Information
7.15.2 Sun Pharmaceutical Description and Business Overview
7.15.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Sun Pharmaceutical Products Offered
7.15.5 Sun Pharmaceutical Recent Development
7.16 Sagent Pharmaceuticals
7.16.1 Sagent Pharmaceuticals Corporation Information
7.16.2 Sagent Pharmaceuticals Description and Business Overview
7.16.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Sagent Pharmaceuticals Products Offered
7.16.5 Sagent Pharmaceuticals Recent Development
7.17 Aurobindo Pharma
7.17.1 Aurobindo Pharma Corporation Information
7.17.2 Aurobindo Pharma Description and Business Overview
7.17.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Aurobindo Pharma Products Offered
7.17.5 Aurobindo Pharma Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Ketorolac Tromethamine Industry Chain Analysis
8.2 Ketorolac Tromethamine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Ketorolac Tromethamine Distributors
8.3 Ketorolac Tromethamine Production Mode & Process
8.4 Ketorolac Tromethamine Sales and Marketing
8.4.1 Ketorolac Tromethamine Sales Channels
8.4.2 Ketorolac Tromethamine Distributors
8.5 Ketorolac Tromethamine Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Ketorolac Tromethamine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Ketorolac Tromethamine Market Trends
Table 3. Ketorolac Tromethamine Market Drivers
Table 4. Ketorolac Tromethamine Market Challenges
Table 5. Ketorolac Tromethamine Market Restraints
Table 6. Global Ketorolac Tromethamine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Ketorolac Tromethamine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Ketorolac Tromethamine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Ketorolac Tromethamine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Ketorolac Tromethamine Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Ketorolac Tromethamine Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Ketorolac Tromethamine Revenue Share by Manufacturer, 2017-2022
Table 13. Global Ketorolac Tromethamine Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Ketorolac Tromethamine Sales Share by Manufacturer, 2017-2022
Table 15. Global Ketorolac Tromethamine Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Ketorolac Tromethamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Ketorolac Tromethamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac Tromethamine as of 2021)
Table 18. Top Players of Ketorolac Tromethamine in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Ketorolac Tromethamine Product Type
Table 20. Date of International Manufacturers Enter into Ketorolac Tromethamine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Ketorolac Tromethamine Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Ketorolac Tromethamine Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Ketorolac Tromethamine Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Ketorolac Tromethamine Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Ketorolac Tromethamine Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Ketorolac Tromethamine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Ketorolac Tromethamine Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Ketorolac Tromethamine Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Ketorolac Tromethamine Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Ketorolac Tromethamine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Ketorolac Tromethamine Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Ketorolac Tromethamine Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Ketorolac Tromethamine Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Ketorolac Tromethamine Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Ketorolac Tromethamine Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Ketorolac Tromethamine Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Ketorolac Tromethamine Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Ketorolac Tromethamine Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Ketorolac Tromethamine Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Ketorolac Tromethamine Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Pfizer Corporation Information
Table 43. Pfizer Description and Business Overview
Table 44. Pfizer Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Pfizer Ketorolac Tromethamine Product
Table 46. Pfizer Recent Development
Table 47. Omeros Corporation Corporation Information
Table 48. Omeros Corporation Description and Business Overview
Table 49. Omeros Corporation Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Omeros Corporation Product
Table 51. Omeros Corporation Recent Development
Table 52. Egalet US Inc. Corporation Information
Table 53. Egalet US Inc. Description and Business Overview
Table 54. Egalet US Inc. Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Egalet US Inc. Product
Table 56. Egalet US Inc. Recent Development
Table 57. Allergan Corporation Information
Table 58. Allergan Description and Business Overview
Table 59. Allergan Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Allergan Product
Table 61. Allergan Recent Development
Table 62. Dr. Reddy?s Laboratories Corporation Information
Table 63. Dr. Reddy?s Laboratories Description and Business Overview
Table 64. Dr. Reddy?s Laboratories Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Dr. Reddy?s Laboratories Product
Table 66. Dr. Reddy?s Laboratories Recent Development
Table 67. Teva Corporation Information
Table 68. Teva Description and Business Overview
Table 69. Teva Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Teva Product
Table 71. Teva Recent Development
Table 72. Mylan Corporation Information
Table 73. Mylan Description and Business Overview
Table 74. Mylan Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Mylan Product
Table 76. Mylan Recent Development
Table 77. West Ward Pharmaceuticals Corporation Information
Table 78. West Ward Pharmaceuticals Description and Business Overview
Table 79. West Ward Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. West Ward Pharmaceuticals Product
Table 81. West Ward Pharmaceuticals Recent Development
Table 82. Fresenius Kabi Corporation Information
Table 83. Fresenius Kabi Description and Business Overview
Table 84. Fresenius Kabi Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Fresenius Kabi Product
Table 86. Fresenius Kabi Recent Development
Table 87. Apotex Corporation Information
Table 88. Apotex Description and Business Overview
Table 89. Apotex Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Apotex Product
Table 91. Apotex Recent Development
Table 92. Sandoz Corporation Information
Table 93. Sandoz Description and Business Overview
Table 94. Sandoz Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Sandoz Product
Table 96. Sandoz Recent Development
Table 97. Amphastar Pharmaceuticals Corporation Information
Table 98. Amphastar Pharmaceuticals Description and Business Overview
Table 99. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Amphastar Pharmaceuticals Product
Table 101. Amphastar Pharmaceuticals Recent Development
Table 102. Gland Pharma Limited Corporation Information
Table 103. Gland Pharma Limited Description and Business Overview
Table 104. Gland Pharma Limited Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. Gland Pharma Limited Product
Table 106. Gland Pharma Limited Recent Development
Table 107. Akorn Corporation Information
Table 108. Akorn Description and Business Overview
Table 109. Akorn Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Akorn Product
Table 111. Akorn Recent Development
Table 112. Sun Pharmaceutical Corporation Information
Table 113. Sun Pharmaceutical Description and Business Overview
Table 114. Sun Pharmaceutical Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Sun Pharmaceutical Product
Table 116. Sun Pharmaceutical Recent Development
Table 117. Sagent Pharmaceuticals Corporation Information
Table 118. Sagent Pharmaceuticals Description and Business Overview
Table 119. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Sagent Pharmaceuticals Product
Table 121. Sagent Pharmaceuticals Recent Development
Table 122. Aurobindo Pharma Corporation Information
Table 123. Aurobindo Pharma Description and Business Overview
Table 124. Aurobindo Pharma Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Aurobindo Pharma Product
Table 126. Aurobindo Pharma Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Ketorolac Tromethamine Customers List
Table 130. Ketorolac Tromethamine Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Ketorolac Tromethamine Product Picture
Figure 2. Global Ketorolac Tromethamine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Ketorolac Tromethamine Market Size 2017-2028 (US$ Million)
Figure 4. Global Ketorolac Tromethamine Sales 2017-2028 (K Units)
Figure 5. United States Ketorolac Tromethamine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Ketorolac Tromethamine Market Size 2017-2028 (US$ Million)
Figure 7. United States Ketorolac Tromethamine Sales 2017-2028 (K Units)
Figure 8. United States Ketorolac Tromethamine Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Ketorolac Tromethamine Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Ketorolac Tromethamine Report Years Considered
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Ophthalmic
Figure 13. Product Picture of Nasal
Figure 14. Product Picture of Oral tablet
Figure 15. Global Ketorolac Tromethamine Market Share by Type in 2022 & 2028
Figure 16. Global Ketorolac Tromethamine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Ketorolac Tromethamine Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Ketorolac Tromethamine Sales by Type (2017-2028) & (K Units)
Figure 19. Global Ketorolac Tromethamine Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Ketorolac Tromethamine Price by Type (2017-2028) & (USD/Unit)
Figure 21. United States Ketorolac Tromethamine Market Share by Type in 2022 & 2028
Figure 22. United States Ketorolac Tromethamine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Ketorolac Tromethamine Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Ketorolac Tromethamine Sales by Type (2017-2028) & (K Units)
Figure 25. United States Ketorolac Tromethamine Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Ketorolac Tromethamine Price by Type (2017-2028) & (USD/Unit)
Figure 27. Product Picture of Short-term treatment of pain
Figure 28. Product Picture of Ophthalmic Surgery
Figure 29. Global Ketorolac Tromethamine Market Share by Application in 2022 & 2028
Figure 30. Global Ketorolac Tromethamine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Ketorolac Tromethamine Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Ketorolac Tromethamine Sales by Application (2017-2028) & (K Units)
Figure 33. Global Ketorolac Tromethamine Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Ketorolac Tromethamine Price by Application (2017-2028) & (USD/Unit)
Figure 35. United States Ketorolac Tromethamine Market Share by Application in 2022 & 2028
Figure 36. United States Ketorolac Tromethamine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Ketorolac Tromethamine Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Ketorolac Tromethamine Sales by Application (2017-2028) & (K Units)
Figure 39. United States Ketorolac Tromethamine Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Ketorolac Tromethamine Price by Application (2017-2028) & (USD/Unit)
Figure 41. North America Ketorolac Tromethamine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 42. North America Ketorolac Tromethamine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Ketorolac Tromethamine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 46. Europe Ketorolac Tromethamine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Ketorolac Tromethamine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 53. Asia-Pacific Ketorolac Tromethamine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Ketorolac Tromethamine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 65. Latin America Ketorolac Tromethamine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Ketorolac Tromethamine Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 70. Middle East & Africa Ketorolac Tromethamine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. U.A.E Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Ketorolac Tromethamine Value Chain
Figure 75. Ketorolac Tromethamine Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Ketorolac Tromethamine Market

Leave This Empty: